[1]
Jeyanthi Ramanarayanan 2024. Advancements in Tyrosine Kinase Inhibitors Therapy: Role of Imatinib, the First Targeted Treatment for Chronic Myeloid Leukemia . Medicine and Medical Research: New Perspectives Vol. 3. (Aug. 2024), 30–44. DOI:https://doi.org/10.9734/bpi/mmrnp/v3/1238.